These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6758690)

  • 1. Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates.
    Defever KS; Whelan WL; Rogers AL; Beneke ES; Veselenak JM; Soll DR
    Antimicrob Agents Chemother; 1982 Nov; 22(5):810-5. PubMed ID: 6758690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segregation of 5-fluorocytosine-resistance variants by Candida albicans.
    Whelan WL; Beneke ES; Rogers AL; Soll DR
    Antimicrob Agents Chemother; 1981 Jun; 19(6):1078-81. PubMed ID: 7023383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased activity of UMP pyrophosphorylase associated with resistance to 5-fluorocytosine in Candida albicans.
    Whelan WL; Kerridge D
    Antimicrob Agents Chemother; 1984 Oct; 26(4):570-4. PubMed ID: 6393861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complementation analysis of resistance to 5-fluorocytosine in Candida albicans.
    Whelan WL; Markie D; Kwon-Chung KJ
    Antimicrob Agents Chemother; 1986 May; 29(5):726-9. PubMed ID: 3524427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenicity in mice of strains of Candida albicans with different in vitro sensitivity to 5-fluorocytosine.
    Persson M; Winblad B; Anséhn S; Schönebeck J
    Scand J Infect Dis; 1978; 10(1):87-90. PubMed ID: 345424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The susceptibility of Candida albicans to amphotericin B, nystatin, and 5-fluorocytosine.
    Hamra LK; Pankiewicz IJ
    Med J Aust; 1977 Nov; 2(22):749-50. PubMed ID: 347230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [C. albicans spontaneous mutations determining 5-fluorocytosine resistance].
    Pawlik B; Barylak J
    Med Dosw Mikrobiol; 1977; 29(4):301-7. PubMed ID: 340821
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergism of amphotericin B and 5-fluorocytosine for candida species.
    Montgomerie JZ; Edwards JE; Guze LB
    J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States.
    Stiller RL; Bennett JE; Scholer HJ; Wall M; Polak A; Stevens DA
    Antimicrob Agents Chemother; 1982 Sep; 22(3):482-7. PubMed ID: 6753737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates.
    Nobre G; Sobral T; Ferreira AF
    Mycopathologia; 1981 Jan; 73(1):39-41. PubMed ID: 7012631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 19F nuclear magnetic resonance study of uptake and metabolism of 5-fluorocytosine in susceptible and resistant strains of Candida albicans.
    Di Vito M; Podo F; Torosantucci A; Carpinelli G; Whelan WL; Kerridge D; Cassone A
    Antimicrob Agents Chemother; 1986 Feb; 29(2):303-8. PubMed ID: 3521476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.
    Utz CJ; Shadomy S
    J Infect Dis; 1977 Jun; 135(6):970-4. PubMed ID: 325150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro studies of 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata.
    Normark S; Schönebeck J
    Antimicrob Agents Chemother; 1972 Sep; 2(3):114-21. PubMed ID: 4597703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity of 5-fluorocytosine resistant strains of Candida albicans.
    Fasoli MO; Kerridge D; Ryley JF
    J Med Vet Mycol; 1990; 28(1):27-34. PubMed ID: 2194016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity and resistance of pathogenic yeasts to 5-fluoropyrimidines. I.--Relation between the phenotypes of resistance to 5-fluorocytosine, the serotype of Candida albicans and the ecology of various species of Candida of human origin (author's transl)].
    Drouhet E; Mercier-Soucy L; Montplaisir S
    Ann Microbiol (Paris); 1975; 126B(1):25-39. PubMed ID: 1108732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of 5-fluorocytosine.
    Waldorf AR; Polak A
    Antimicrob Agents Chemother; 1983 Jan; 23(1):79-85. PubMed ID: 6338821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further evidence for sequential action of amphotericin B and 5-fluorocytosine against Candida albicans.
    Beggs WH; Sarosi GA
    Chemotherapy; 1982; 28(5):341-4. PubMed ID: 6754278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sensitivity and resistance of Candida to 5-fluorocytosine. Relationship to the cell wall ultrastructure].
    Montplaisir S; Drouhet E; Nabarra B
    C R Acad Hebd Seances Acad Sci D; 1975 May; 280(19):2211-3. PubMed ID: 807407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans.
    Dodgson AR; Dodgson KJ; Pujol C; Pfaller MA; Soll DR
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2223-7. PubMed ID: 15155225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sensitivity of clinical isolates of Candida albicans to 5-fluorocytosine].
    Fernández Andreu CM; Lemus Molina D; Martínez Machín G
    Rev Cubana Med Trop; 2000; 52(3):191-6. PubMed ID: 11826522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.